NCT06416852View on ClinicalTrials.gov

Clinical Study of 18F-Alfatide Injection PET/CT

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

428

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2026

Conditions
Non-Small Cell Lung Cancer NSCLC
Interventions
DRUG

18F-Alfatide Injection

A single dose of (0.1\~0.15）±0.015 mCi/kg IV injection of 18F-Alfatide. The patients will be intravenously injected with 18F-Alfatide Injection and undergo PET/CT scan at 60 min±10 min after the injection.

DRUG

18F-FDG Injection

A single dose of 5～10mCi IV injection of 18F-FDG. The patients will be intravenously injected with 18F-FDG Injection and undergo PET/CT scan at 40 min±10 min after the injection.

Trial Locations (1)

430000

Wuhan Union Hospital, Wuhan

All Listed Sponsors
lead

Yantai LNC Biotechnology Singapore PTE. LTD.

INDUSTRY